Celltrion Pharm, Inc.
4 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| A Study to Evaluate the Effect of add-on Pioglitazone or Dapagliflozin in Participants With Type 2 Diabetes Mellitus Inadequately Controlled by DPP-4 Inhibitor and Metformin Therapy (NCT03499704) | Celltrion Pharm, Inc. | 2020-02-11 |
| A Study for PMS of AZL-M/CLD FDC in the Treatment of Participants With Essential HTN in South Korea (NCT04470830) | Celltrion Pharm, Inc. | 2019-09-11 |
| A Study for PMS of AZL-M in the Treatment of Adult Participants With Essential Hypertension in South Korea (NCT04470817) | Celltrion Pharm, Inc. | 2018-08-07 |
Track Celltrion Pharm, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.